Revie, Nicole M.
Iyer, Kali R.
Maxson, Michelle E. https://orcid.org/0000-0002-1493-490X
Zhang, Jiabao
Yan, Su
Fernandes, Caroline M.
Meyer, Kirsten J. https://orcid.org/0000-0001-9487-7361
Chen, Xuefei
Skulska, Iwona
Fogal, Meea https://orcid.org/0000-0002-0483-9626
Sanchez, Hiram https://orcid.org/0000-0002-6286-650X
Hossain, Saif
Li, Sheena
Yashiroda, Yoko
Hirano, Hiroyuki https://orcid.org/0000-0002-0761-5548
Yoshida, Minoru https://orcid.org/0000-0002-4376-5674
Osada, Hiroyuki https://orcid.org/0000-0002-3606-4925
Boone, Charles https://orcid.org/0000-0002-3542-6760
Shapiro, Rebecca S. https://orcid.org/0000-0002-7119-8865
Andes, David R. https://orcid.org/0000-0002-7927-9950
Wright, Gerard D. https://orcid.org/0000-0002-9129-7131
Nodwell, Justin R. https://orcid.org/0000-0001-7909-1803
Del Poeta, Maurizio
Burke, Martin D. https://orcid.org/0000-0001-7963-7140
Whitesell, Luke https://orcid.org/0000-0001-6445-5766
Robbins, Nicole
Cowen, Leah E. https://orcid.org/0000-0001-5797-0110
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (MFE-176478, FDN-143264, FDN-154288)
MEXT | Japan Society for the Promotion of Science (JP19H05640, 17H06411)
U.S. Department of Health & Human Services | National Institutes of Health (R01AI073289, AI116420, AI125770, R01 5R01AI135812)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 9 August 2021
Accepted: 14 June 2022
First Online: 25 June 2022
Competing interests
: L.E.C. and L.W. are co-founders of and shareholders in Bright Angel Therapeutics, a platform company for development of novel antifungal therapeutics. M.D.P. is a co-Founder and chief scientific officer (CSO) of MicroRid Technologies Inc. M.D.B. is a (co)-Founder, consultant, and shareholder for REVOLUTION Medicines, Ambys Medicines, Sfunga Therapeutics, Cystetic Medicines, and Kinesid Therapeutics. The remaining authors declare no competing interests.